Source: Ruslan Ivantsov / Shutterstock.com Wall Street has officially entered a bear market. Macroeconomic headwinds continue to build, including rampant inflation, slowing economic growth and continued geopolitical turmoil. We now have further uncertainty surrounding the stock market following the most recent interest rate hike. As we enter a bear market, investors are searching for alternative investment paths for diversification. Growth names that were the darlings on Wall Street during the pandemic have not been immune to these challenges so far in the year. Even large-capitalization (cap) shares have come under pressure since January. Year-to-date (YTD), the S&P 500 index has so far dropped over 22.9% year-to-date (YTD), while the tech-heavy Nasdaq 100 has declined more than 30.7% during the same period. In the past century, we have had over 25 bear markets on the Street. Most have lasted an average of less than one year. While it may be tempting to sell stocks in the portfolio to minimize losses, panic selling in a bear market often leads to loss of potential profits and even investment capital.
→ Google 翻译
WILMINGTON, DE / ACCESSWIRE / September 26, 2022 / Transparency Market Research Inc. - Rising use of automation in various healthcare and biotech research processes is creating attractive opportunities in the global molecular diagnostics market . This trend is further bolstered by the rising need for incorporating automation for facilitating various processes, including extraction of DNA, amplification, and analyzing and recording healthcare data. These automated systems offer various benefits, such as higher efficiency, precise output, and reduced time required for gaining results. Based on a recent research report, the global molecular diagnostics market is estimated to rise at a CAGR of 11.1% over the forecast period of 2021 to 2028. Get Exclusive PDF Sample Copy of Molecular Diagnostics Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1783 Growing adoption of molecular diagnostic devices in various diagnostic laboratories, biotech and pharma companies, hospitals, and research and academic institutes is creating growth opportunities for players in the global molecular diagnostics market in developed economies.
→ Google 翻译
Major players in the immunofluorescence assay market are Thermo Fisher Scientific, Inc. , Abcam plc, Bio-Rad Laboratories, Inc. , PerkinElmer Inc. , Werfen Company, Merck KGaA, Agilent Technologies, Becton Dickinson and Company, Maxvision Biosciences Inc. Major players in the immunofluorescence assay market are Thermo Fisher Scientific, Inc. , Abcam plc, Bio-Rad Laboratories, Inc. , PerkinElmer Inc. , Werfen Company, Merck KGaA, Agilent Technologies, Becton Dickinson and Company, Maxvision Biosciences Inc.
→ Google 翻译
The exclusive research study on ''Stem Cell Assay Market,'' which is now accessible with Coherent Market Insights, provides a complete overview of the elements driving the global business environment. This study also contains comprehensive information on the market size, commercialization
→ Google 翻译
Major players in the multiplex assays market are Thermo Fisher Scientific, Inc. , Luminex Corporation, Illumina, Inc, Bio-Rad Laboratories, Inc, QIAGEN N. V, Becton, Dickinson and Company, Bühlmann Laboratories, Seegene Inc, Meso Scale Diagnostics LLC. Major players in the multiplex assays market are Thermo Fisher Scientific, Inc. , Luminex Corporation, Illumina, Inc, Bio-Rad Laboratories, Inc, QIAGEN N. V, Becton, Dickinson and Company, Bühlmann Laboratories, Seegene Inc, Meso Scale Diagnostics LLC.
→ Google 翻译
New York, USA, May 26, 2022 (GLOBE NEWSWIRE) -- The Global Next-Generation Sequencing Market to register Sustainable Growth at a CAGR of 18.96% During the Study Period (2018-26), Assesses DelveInsight As per DelveInsight Analysis in the Next-Generation Sequencing market, the growing application of the Next-Generation Sequencing technology in various fields such as clinical diagnosis, scientific research, and others is projected to propel the Next-Generation Sequencing market. Additionally, the advancement in the Next-Generation Sequencing platform is likely to increase the adoption of Next-Generation Sequencing technology thereby driving Next-Generation Sequencing market growth in the forthcoming years. According to the latest report published by DelveInsight " Next Generation Sequencing Market Insight , the global Next-Generation Sequencing market is expected to witness significant growth owing to the rise in cases of infectious diseases and various other complex disorders such as cancer, genetic disorders, and others across the globe.
→ Google 翻译
Major players in the sample preparation market are Agilent Technologies, Bio-Rad Laboratories, Danaher Corporation, Illumina, Qiagen NV, PerkinElmer, F Hoffman La Roche, Tecan Group Ltd, Hamilton Company, and Norgen Biotek Corporation. Major players in the sample preparation market are Agilent Technologies, Bio-Rad Laboratories, Danaher Corporation, Illumina, Qiagen NV, PerkinElmer, F Hoffman La Roche, Tecan Group Ltd, Hamilton Company, and Norgen Biotek Corporation.
→ Google 翻译
Here are seven asset classes, including stocks in different industries, that could offer shelter during a bear market Blue chip companies are those that investors have typically known for decades. Worldwide spending on healthcare should continue to grow during the decade. Prices of commodities are expected to remain at historically high levels by the end of 2024. Wall Street offer several options to invest in the growth of real estate . Utility stocks boast modest but steady growth and above-average dividend yields. Cryptocurrency investors should diversify their investments across different digital assets. Art and NFT prices can act independently of moves in equities. Source: Ruslan Ivantsov / Shutterstock.com It looks like Wall Street is bracing for a bear market. Macroeconomic headwinds continue to build, including rampant inflation, slowing economic growth, geopolitical turmoil, and Covid-19 lockdowns in Asia. We now have further uncertainty surrounding the stock market following the most recent interest rate hike.
→ Google 翻译